British PM Cameron Urges G7 Leaders To Take Action On Drug Resistance, Establish R&D Reward Fund

Financial Times: Cameron pushes for action on ‘superbugs’
“David Cameron will on Friday urge world leaders to set up a global fund worth $1.6bn a year to reward pharmaceutical companies that develop drugs to fight ‘superbugs.’ The prime minister will present to the Group of Seven summit a report on antimicrobial resistance by Lord Jim O’Neill, the former Goldman Sachs chief economist, who has proposed a global drug development fund worth $16bn over 10 years…” (Parker/Ward, 5/27).

Reuters: G7 told to act on antibiotics as dreaded superbug hits U.S.
“Britain told the G7 industrial powers on Friday to do more to fight killer superbugs as the United States reported the first case in the country of a patient with bacteria resistant to a last-resort antibiotic. … In Japan, British Prime Minister David Cameron said leading countries needed to tackle resistance by reducing the use of antibiotics and rewarding drug companies for developing new medicines…” (MacClellan/Hirschler, 5/27).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.